Cargando…
Tumor slice culture system to assess drug response of primary breast cancer
BACKGROUND: The high incidence of breast cancer has sparked the development of novel targeted and personalized therapies. Personalization of cancer treatment requires reliable prediction of chemotherapy responses in individual patients. Effective selection can prevent unnecessary treatment that woul...
Autores principales: | Naipal, Kishan A. T., Verkaik, Nicole S., Sánchez, Humberto, van Deurzen, Carolien H. M., den Bakker, Michael A., Hoeijmakers, Jan H.J., Kanaar, Roland, Vreeswijk, Maaike P.G., Jager, Agnes, van Gent, Dik C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748539/ https://www.ncbi.nlm.nih.gov/pubmed/26860465 http://dx.doi.org/10.1186/s12885-016-2119-2 |
Ejemplares similares
-
Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer
por: Ladan, Marjolijn M., et al.
Publicado: (2022) -
Ex vivo tumor culture systems for functional drug testing and therapy response prediction
por: Meijer, Titia G, et al.
Publicado: (2017) -
Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer
por: Naipal, Kishan A. T., et al.
Publicado: (2015) -
Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
por: van den Tempel, Nathalie, et al.
Publicado: (2018) -
Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients
por: Ladan, Marjolijn M., et al.
Publicado: (2023)